Simplex Trading
NVO

Simplex Trading’s Novo Nordisk NVO Stock Holding History

Simplex Trading’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.8M Sell
2,389,900
-71,800
-3% -$3.4M 0.06% 130
2025
Q4 		$125M Sell
2,461,700
-214,800
-8% -$11M 0.07% 120
2025
Q3 		$149M Buy
2,676,500
+1,756,000
+191% +$103M 0.08% 139
2025
Q2 		$63.5M Sell
920,500
-221,500
-19% -$15.1M 0.04% 241
2025
Q1 		$79.3M Buy
1,142,000
+30,700
+3% +$2.54M 0.05% 178
2024
Q4 		$95.6M Buy
1,111,300
+603,400
+119% +$65.3M 0.05% 171
2024
Q3 		$60.5M Sell
507,900
-224,800
-31% -$30M 0.04% 270
2024
Q2 		$105M Sell
732,700
-103,900
-12% -$13.8M 0.06% 148
2024
Q1 		$107M Buy
836,600
+185,800
+29% +$22.1M 0.06% 162
2023
Q4 		$67.3M Buy
650,800
+83,200
+15% +$8.23M 0.04% 257
2023
Q3 		$51.6M Buy
567,600
+279,600
+97% +$24.6M 0.04% 283
2023
Q2 		$23.3M Buy
288,000
+100,600
+54% +$8.22M 0.02% 519
2023
Q1 		$14.9M Sell
187,400
-97,800
-34% -$6.94M 0.01% 707
2022
Q4 		$19.3M Buy
285,200
+101,200
+55% +$5.93M 0.02% 570
2022
Q3 		$9.16M Buy
184,000
+98,400
+115% +$5.27M 0.01% 843
2022
Q2 		$4.77M Buy
85,600
+27,800
+48% +$1.54M 0.01% 1176
2022
Q1 		$3.21M Sell
57,800
-21,000
-27% -$1.08M ﹤0.01% 1638
2021
Q4 		$4.41M Buy
78,800
+15,600
+25% +$845K ﹤0.01% 1306
2021
Q3 		$2.67M Sell
63,200
-1,000
-2% -$48.3K ﹤0.01% 1802
2021
Q2 		$2.69M Buy
64,200
+63,496
+9,019% +$2.46M ﹤0.01% 1800
2021
Q1 		$2.37M Sell
704
-220
-24% -$7.84K ﹤0.01% 1434
2020
Q4 		$3.23M Buy
924
+506
+121% +$17.5K ﹤0.01% 1326
2020
Q3 		$1.45M Buy
418
+68
+19% +$2.27K ﹤0.01% 1843
2020
Q2 		$1.15M Sell
350
-116
-25% -$3.7K ﹤0.01% 2019
2020
Q1 		$1.4M Buy
466
+8
+2% +$238 ﹤0.01% 1574
2019
Q4 		$1.32M Sell
458
-694
-60% -$19.2K ﹤0.01% 1831
2019
Q3 		$2.98M Buy
1,152
+656
+132% +$16.6K 0.01% 1030
2019
Q2 		$1.26M Sell
496
-616
-55% -$15.2K ﹤0.01% 1696
2019
Q1 		$2.91M Buy
1,112
+250
+29% +$6.14K 0.01% 1054
2018
Q4 		$1.99M Buy
862
+468
+119% +$10.4K 0.01% 1095
2018
Q3 		$928K Buy
394
+206
+110% +$5.03K ﹤0.01% 1974
2018
Q2 		$433K Buy
188
+24
+15% +$570 ﹤0.01% 2609
2018
Q1 		$12K Sell
164
-372
-69% -$9.77K ﹤0.01% 3874
2017
Q4 		$24K Buy
536
+92
+21% +$2.34K ﹤0.01% 3135
2017
Q3 		$39K Buy
444
+204
+85% +$4.61K ﹤0.01% 2536
2017
Q2 		$30K Sell
240
-300
-56% -$6.05K ﹤0.01% 2893
2017
Q1 		$15K Buy
540
+430
+391% +$7.49K ﹤0.01% 3577
2016
Q4 		$8K Sell
110
-428
-80% -$7.76K ﹤0.01% 3937
2016
Q3 		$10K Buy
538
+226
+72% +$5.6K ﹤0.01% 3627
2016
Q2 		$11K Sell
312
-256
-45% -$7.02K ﹤0.01% 3519
2016
Q1 		$82K Buy
568
+436
+330% +$11.7K 0.01% 1524
2015
Q4 		$9K Sell
132
-1,170
-90% -$32.4K ﹤0.01% 3406
2015
Q3 		$20K Buy
1,302
+1,276
+4,908% +$36.1K ﹤0.01% 2803
2015
Q2 		$4K Sell
26
-54
-68% -$1.52K ﹤0.01% 3840
2015
Q1 		$16K Buy
80
+46
+135% +$1.06K ﹤0.01% 2501
2014
Q4 		$1K Buy
+34
New +$759 ﹤0.01% 4203

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Simplex Trading's NVO Position: Q1 2026 in Review

Simplex Trading reduced its Novo Nordisk (NVO) stake by 61% in Q1 2026, selling an estimated $29.6M and leaving 392,803 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #542.

Simplex Trading first reported a position in NVO in Q1 2015 and has held it in 30 quarters since. The position peaked at $51.8M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Simplex Trading held 392,803 shares of Novo Nordisk worth $14.4M as of Q1 2026.
  • Simplex Trading sold 624,359 Novo Nordisk shares in Q1 2026, an estimated $29.6M.
  • Novo Nordisk made up 0.01% of Simplex Trading's portfolio in Q1 2026, its #542 holding.
  • Simplex Trading first reported a position in Novo Nordisk in Q1 2015 and has held it in 30 quarters since.
  • Simplex Trading's Novo Nordisk position peaked at $51.8M in Q4 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.